688359 三孚新科
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)1.772-8.797-2.536-7.691-6.327
总资产报酬率 ROA (%)0.809-3.698-1.014-3.744-4.613
投入资产回报率 ROIC (%)1.085-4.891-1.319-4.666-5.331

边际利润分析
销售毛利率 (%)30.73236.21738.28132.17429.872
营业利润率 (%)4.317-17.205-0.396-9.209-12.629
息税前利润/营业总收入 (%)6.018-14.7751.637-7.619-13.013
净利润/营业总收入 (%)4.955-13.2240.711-6.999-10.004

收益指标分析
经营活动净收益/利润总额(%)37.34875.773480.30890.18886.137
价值变动净收益/利润总额(%)26.657-7.327-736.617-13.248-1.242
营业外收支净额/利润总额(%)-0.2980.3965.382-0.0084.203

偿债能力分析
流动比率 (X)1.5001.4271.2571.2842.124
速动比率 (X)1.2141.1111.0521.0691.855
资产负债率 (%)45.12747.63049.21149.77636.939
带息债务/全部投入资本 (%)32.05136.46440.48735.55816.161
股东权益/带息债务 (%)196.684162.185128.440146.423451.739
股东权益/负债合计 (%)104.51292.33381.27380.278169.692
利息保障倍数 (X)3.513-5.9150.796-4.793-76.333

营运能力分析
应收账款周转天数 (天)163.574252.188179.105168.480181.600
存货周转天数 (天)124.541161.91392.75976.24872.777